Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.7 EUR | -1.27% | -.--% | -8.24% |
Mar. 14 | Hyloris Pharmaceuticals SA Provides Earnings Guidance for 2024 | CI |
Mar. 14 | Transcript : Hyloris Pharmaceuticals SA, 2023 Earnings Call, Mar 14, 2024 |
Sales 2024 * | 8.15M 8.8M | Sales 2025 * | 11.95M 12.91M | Capitalization | 328M 354M |
---|---|---|---|---|---|
Net income 2024 * | -14M -15.12M | Net income 2025 * | -13M -14.04M | EV / Sales 2024 * | 38.8 x |
Net cash position 2024 * | 11.6M 12.53M | Net Debt 2025 * | 3.5M 3.78M | EV / Sales 2025 * | 27.7 x |
P/E ratio 2024 * |
-23.4
x | P/E ratio 2025 * |
-24.9
x | Employees | 42 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 43.38% |
Latest transcript on Hyloris Pharmaceuticals SA
1 day | -1.27% | ||
3 months | -6.40% | ||
6 months | -6.77% | ||
Current year | -8.24% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Jacobsen
FOU | Founder | 50 | 11-12-31 |
Stijn van Rompay
FOU | Founder | 48 | 11-12-31 |
Director of Finance/CFO | 53 | 21-09-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Carolyn Myers
BRD | Director/Board Member | 66 | 19-12-31 |
James Gale
BRD | Director/Board Member | 74 | 19-12-31 |
Leon van Rompay
BRD | Director/Board Member | 75 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 11.7 | -.--% | 0 |
24-06-06 | 11.7 | -.--% | 0 |
24-06-05 | 11.7 | -.--% | 0 |
24-06-04 | 11.7 | -.--% | 0 |
24-06-03 | 11.7 | -.--% | 0 |
Real-time Euronext Bruxelles, April 26, 2024 at 11:37 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-8.24% | 354M | |
+45.82% | 765B | |
+40.95% | 632B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.45% | 248B | |
-0.78% | 219B | |
+11.88% | 216B | |
+5.90% | 164B |
- Stock Market
- Equities
- HYL Stock